Skip to main content
. Author manuscript; available in PMC: 2017 Aug 1.
Published in final edited form as: Pharmacol Res. 2016 May 6;110:10–24. doi: 10.1016/j.phrs.2016.04.028

Figure 11. Efavirenz modestly inhibits monoamine oxidase-A.

Figure 11

Efavirenz (10 μM) decreases the activity of MAO-A by 36 ± 1.7%. The mean value from multiple experiments ± SEM is plotted. Student’s t-test was used to determine statistical significance (P < 0.05).